A diminished expression of PRMT1 (protein arginine methyltransferase 1) and its target asymmetric dimethyl H4R3 mark in IDH1-MT was concomitant with reduced PTX3 in IDH1-MT glioma cells and in patients. Here, PRMT1 is linked to glioma.